Birmingham, AL, United States of America

De-Chu C Tang

This inventor holds 11 USPTO granted patents and 5 published patent applications, plus 2 CIPO patents and 5 EPO patents. Top assignees: Altimmune, Inc., The UAB Research Foundation (The University of Alabama at Birmingham), Auburn University. Active years: 2002-2020.

IDiyas Innovation Intelligence. (2026). Inventor Profile: De-Chu C Tang. Retrieved from https://idiyas.com/inventor/de-chu-c-tang

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 11 

% Patents Active = 63.6


 

Average Co-Inventor Count = 2.1

ph-index = 5

Forward Citations = 154(Granted Patents)


Location History:

  • Hoover, AL (US) (2009)
  • Birmingham, AL (US) (2002 - 2019)
  • Gaithersburg, MD (US) (2018 - 2020)

Company Filing History:


Years Active: 2002-2020

Loading Chart...
Loading Chart...
Loading Chart...
11 patents (USPTO):Explore Patents

Title: Innovator De-Chu C. Tang: Advancements in Avian Immunization

Introduction

De-Chu C. Tang, a prolific inventor based in Birmingham, AL, has made significant contributions to the fields of immunology and vaccine technology. With a total of 11 patents to his name, his work primarily focuses on the development of innovative vaccines aimed at improving the health and immunization of avian species.

Latest Patents

Two of his latest patents reveal the depth of his research and the impact of his innovations. The first patent, titled "Immunization of avians by administration of non-replicating vectored vaccines," describes a method utilizing recombinant human adenovirus vectors to deliver avian immunogens and antigens, including avian influenza, into avians. This invention also outlines methods for introducing and expressing these immunogens in avian subjects, including embryos, effectively eliciting an immunogenic response.

His second groundbreaking patent, "Rapid and prolonged immunologic-therapeutic," details how intranasal administration of E1/E3-defective adenovirus particles can provide rapid and broad protection against various viral and bacterial pathogens. The studies indicated that protective responses could last for many weeks after a single-dose regimen in animal models, showcasing the potential for innovative vaccine protocols in the prevention of diseases.

Career Highlights

Over the years, De-Chu C. Tang has contributed to the scientific community through his roles in various organizations. He has worked with Altimmune, Inc. and the UAB Research Foundation, where he utilized his expertise to further research in vaccine development and immunology.

Collaborations

Collaboration has been key to Tang's success, as he has worked alongside esteemed colleagues such as Zhongkai Shi and Donald H. Marks. This teamwork has been instrumental in advancing significant findings in avian immunization techniques and therapeutics.

Conclusion

De-Chu C. Tang’s dedication to innovation in vaccine development signifies a major leap forward in avian health management. His patents reflect not only his ingenuity but also his commitment to protecting avian populations from infectious diseases through advanced immunological methods. With ongoing research and collaborations, Tang continues to inspire future advancements in immunology and vaccine technology.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…